Vera Therapeutics Inc. Financials
VERA
All currency values in $ millions unless otherwise noted
Scroll
| Income Statement | DEC 2025 | DEC 2024 | DEC 2023 ~1.6:1 split | DEC 2022 2:1 split | DEC 2021 42:1 split |
|---|---|---|---|---|---|
| General & Administrative | $100 | $41 | $24 | $22 | $12 |
| Research & Development | $215 | $126 | $78 | $69 | $22 |
| Total Operating Expenses | $315 | $167 | $102 | $91 | $34 |
| Operating Income | -$315 | -$167 | -$102 | -$91 | -$34 |
| Non-Operating | |||||
| Net Interest Expense | $17 | $13 | $4 | $1 | -$0 |
| Other Non-Operating Income (Expense) | -$1 | $2 | $2 | $1 | $2 |
| EBT (Earnings Before Tax) | -$300 | -$152 | -$96 | -$89 | -$33 |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | |||||
| Net Income | -$300 | -$152 | -$96 | -$89 | -$33 |
| EPS (Basic) | -$4.66 | -$2.75 | -$2.25 | -$3.35 | -$2.43 |
| EPS (Diluted) | -$4.66 | -$2.75 | -$2.25 | -$3.35 | -$2.43 |
| Weighted Avg Shares (Basic) | 64.2M | 55.3M | 42.7M | 26.6M | 13.4M |
| Weighted Avg Shares (Diluted) | 64.2M | 55.3M | 42.7M | 26.6M | 13.4M |
| Shares Outstanding | 64.2M | 55.3M | 42.7M | 26.6M | 13.4M |
Vera Therapeutics (VERA) financials: revenue, profit and margins
Vera Therapeutics (VERA) generated about n/a in revenue and -$415 million in net income over the trailing twelve months. Figures are from SEC filings; this is analysis, not investment advice.
Frequently asked
Is Vera Therapeutics profitable?+
Vera Therapeutics reported about -$415 million in net loss over the trailing twelve months. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.
SourceFinancial statements computed from the 10-Q filed 29 Oct 2026, covering the period ending 30 Sept 2026, as reported to the SEC. Data last refreshed 10 Nov 2026. How this is calculated.
Fiscal year ends Dec.
Peers
Pharmaceutical Preparations · Pick stocks to compare with VERA
Held by ETFs
VERA is in 37 US ETFs. The largest of them, with VERA's weight in each:
Spot a number that looks wrong? Check it in VERA's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing VERA
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.